Skip to main content

Hofseth Biocare ASA: ISSUANCE OF NEW SHARES FOLLOWING EXERCISE OF OPTIONS – PRIMARY INSIDER DISCLOSURE

Written by Customer Service on . Posted in Public Companies.

In October 2019, Hofseth BioCare ASA (the “Company”) entered into a consultancy agreement with James Berger. Under the terms of the consultancy agreement, Berger was granted 4,862,800 share options. The vesting of the share options is, inter alia, subject to the market price of the Company’s shares reaching and maintaining various levels over periods of 45 trading days for each level. In addition, 810,800 share options vests at the date falling 9 months from the date of the consultancy agreement, and 810,800 share options vests when the Company reaches a valuation that facilitates that the Company successfully completes a US listing.James Berger has now exercised a total of 1,135,120 share options, as 324,320 share options are exercisable due to the volume weighted average price of the Company’s shares having been at least NOK 8.00 over a period of 45 trading days and 810,800 share options are exercisable as the 9 month anniversary of the date of the consultancy agreement has passed. The exercise price of the share options is NOK 0.01 per share option.On this background, the Board of Directors of the Company has now resolved to issue 1,135,120 new shares to James Berger, at a price of NOK 0.01 per share. The new shares are expected to be delivered to Berger during the middle of September 2020.Following this, James Berger holds 3,267,955 shares in the Company and 5,349,280 share options.The issuance of the new shares imply that the Company’s share capital will increase with NOK 11,351.20. Following completion of the share capital increase, the Company’s share capital will be NOK 3,302,090.01 divided by 330,209,001 shares, each with a par value of NOK 0.01.For further information, please contact:Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.